QC
BIIB icon

QCM Cayman’s Biogen BIIB Stock Holding History

QCM Cayman’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-897
Closed -$220K – 134
2020
Q4 		$220K Buy
+897
New +$231K 0.23% 195
2017
Q2 		– Sell
-1,444
Closed -$395K – 175
2017
Q1 		$395K Buy
+1,444
New +$408K 0.07% 231
2016
Q1 		– Sell
-1,023
Closed -$313K – 201
2015
Q4 		$313K Sell
1,023
-1,466
-59% -$421K 0.26% 63
2015
Q3 		$726K Buy
+2,489
New +$822K 0.24% 40
2015
Q2 		– Sell
-619
Closed -$248K – 187
2015
Q1 		$261K Buy
+619
New +$244K 0.14% 128
2014
Q3 		– Sell
-857
Closed -$270K – 205
2014
Q2 		$270K Buy
+857
New +$258K 0.13% 140
2014
Q1 		– Sell
-2,316
Closed -$735K – 286
2013
Q4 		$647K Buy
+2,316
New +$599K 0.21% 48

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QCM Cayman's BIIB Position: Q1 2021 in Review

QCM Cayman sold out of Biogen (BIIB) in Q1 2021, closing a stake of 897 shares — an estimated $220K sold.

QCM Cayman first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $726K in Q3 2015. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • QCM Cayman reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • QCM Cayman sold 897 Biogen shares in Q1 2021, an estimated $220K.
  • QCM Cayman first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
  • QCM Cayman's Biogen position peaked at $726K in Q3 2015.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on QCM Cayman's 13F filing for Q1 2021, filed 17 May 2021.